Urologic Oncology Articles & Analysis
14 news found
High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, sophisticated healthcare access and distribution, ...
("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology and orthopedics, today announced that it will be exhibiting at the American Urological Association ("AUA") Annual Meeting on May 13-16, 2022 in New Orleans to showcase ...
Dr. Amit Gupta at Beverly Hills Urology said, “Our practice is dedicated to leveraging the latest technologies and techniques that advance patient care. ...
The Society of Urologic Oncology sponsors this highly interactive meeting where attendees participate in discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists. The meeting includes state-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in ...
CMR Surgical – the global surgical robotics business – has today announced the successful completion of high-volume urological procedures at the Sindh Institute of Urology and Transplantation (SIUT) using the next generation surgical robotic system, Versius®, in Pakistan. SIUT is a renowned, charitable institute, providing free state of the art ...
Its primary therapeutic areas of interest include oncology, neurology, urology and dermatology. Ingenew’s current research and development efforts are evaluating proprietary preparations and delivery systems designed to improve the clinical efficacy and reduce toxicity and side effects associated with standard of care. ...
NEW YORK, Sept. 20, 2021 /PRNewswire/ -- Data presented from a cross-validation study at the American Urological Association's (AUA) 2021 Annual Meeting confirms that the miR Sentinel® Prostate Cancer Test can detect and risk-classify prostate cancer at the molecular level with predictive accuracy of over 90%, based on a single urine sample. This validation study follows and confirms the ...
NEW YORK and SAN JUAN, Puerto Rico, Sept. 1, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company focused on transforming global cancer management, the Governor of Puerto Rico, Pedro Pierluisi, and the Puerto Rico Health Insurance Administration ("ASES") join forces today to officially make September 1 "Prostate Cancer Prevention Day". This urgent awareness team effort occurs while the ...
(Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an overview of the Company’s recent developments. ...
NEW YORK, Feb. 25, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be virtually presenting at the 12th Annual Prostate Cancer Awareness Day at the Massachusetts State House ...
Cleveland Diagnostics, Inc., a clinical-stage biotechnology company focused on the development of next-generation diagnostic tests for early detection of cancers, announced today the publication of a health economic analysis in Urology Practice. The publication demonstrates the cost effectiveness and economic utility of Cleveland Diagnostics’ IsoPSA test for the detection ...
Pelv-Ice has created a product line pipeline which includes braces and complimentary therapeutics for pelvic conditions for both men and women ranging from oncology, to urology, orthopedics, and OBGYN. We welcome Proa Medical’s technology and products into our growing family of product ...
Matthew Gdovin, Ph.D., University of Texas – San Antonio Professor and Chief Science Officer of Vitanova Biomedical, the San Antonio, Texas-based biotech company dedicated to delivering transformative cancer therapy utilizing their patented Light-Activated Intracellular Acidosis (LAIA) platform technology, will present at the 2nd International Prostate Cancer Symposium and Inaugural World ...
Epstein, M.D., professor at the departments of Pathology, Urology and Oncology at the Johns Hopkins Hospital Medical Institutions in Baltimore, Md. ...